整形外科手術における新しい技術の導入
PMID: 27490218 ·
S, t, u, a, r, t, , B, , G, o, o, d, m, a, n, ;, , W, i, l, l, i, a, m, , M, , M, i, h, a, l, k, o, ;, , P, a, u, l, , A, , A, n, d, e, r, s, o, n, ;, , K, a, t, h, e, r, i, n, e, , S, a, l, e, ;, , K, e, v, i, n, , J, , B, o, z, i, c
広告
抄録
The introduction of new devices, biologics, and combination products to the orthopaedic marketplace is increasing rapidly. The majority of these new technologies obtain clearance to market by demonstrating substantial equivalence to a predicate (previously approved device) according to the U.S. Food and Drug Administration (FDA) 510(k) process. Surgeons play a critical role in the introduction of new technologies to patients and must take a leadership role in promoting safe, efficacious, appropr
広告
公式ソース
PubMedで見る →データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。